• Exchange: Berlin
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

LT3:GR

2.018 EUR 0.124 6.55%

As of 04:10:18 ET on 10/24/2014.

Snapshot for AxoGen Inc (LT3)

Open: 2.016 Day's Range: 2.016 - 2.018 Volume: 0
Previous Close: 1.894 52wk Range: 1.606 - 3.700 1-Yr Rtn: -33.77%

Stock Chart for LT3

No chart data available.
  • LT3:GR 2.018
  • 1D
  • 1M
  • 1Y
1.894
Interactive LT3 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LT3

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.8670
Est. PEG Ratio -
Market Cap (M EUR) 35.25
Shares Outstanding (M) 17.47
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 1.0000
Dividend Ex-Date 01/27/2010
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LT3

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LT3

AxoGen Corp is a regenerative medicine company focused on the development and commercialization of technologies for peripheral nerve reconstruction and regeneration. The Company offers products to help repair peripheral nerves.

Karen ZaderejPresident/CEOLee Robert Johnston Jr "Bob"Chief Financial Officer
Gregory G FreitagSenior VP:Bus Dev/General CnslShawn F McCarreySenior VP:Sales
More Company Profile & Key Executives for LT3

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil